The negotiations are anticipated to close within the next two weeks with an initial order of $250,000. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com. This website uses cookies to improve your experience while you navigate through the website. “We are thrilled at how rapidly our products are being accepted and recognized in the marketplace. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. | Source: June 18, 2019 08:00 ET CBD life sciences subsidiaries builds on natural Operations on, the under Assistance the respective Active substances supplied be. This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CBDL through its wholly owned subsidiary LBC Bioscience Inc. manufactures and sells a full line of […] CBD Life Sciences Inc. announced that it will now provide hemp oil and hemp derived CBD product testing for product manufacturers, retailers and consumers. Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. CBD Life Sciences Inc. is proud to announce that the company is in the Final Stages with getting its Hemp products on Amazon. SCOTTSDALE, AZ / ACCESSWIRE / March 25, 2020 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience “LBC BIO” is pleased to announce in addition to our two stores , we have finalized the formulization of our “NEW PRODUCT” PROPRIETARY PURE CBD TABLET.The product will be packaged in a jar that will consist of 30 tablets. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) today announces that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), has finalized development of … | Source: CBD Life Sciences Subsidiary Developing Line of CBD Based Coffee Products Including Weight Loss Coffee & Brain Booster July 09, 2019 08:00 ET | Source: CBD Life Sciences Inc. CBD Life Sciences … See Optium Cyber Systems, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. CBDL CBD Life Sciences Subsidiary LBC Bioscience Launches First CBD Proprietary Tablet. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. The product is now undergoing final market testing and is expected to be available for purchase within the next three to four weeks. CBD Life Sciences Inc. is working with two different strains of Delta-10 Cartridges. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol … LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com. LBC currently offers the following high-quality line of organic cannabidiol based supplements and wellness products: -        CBD Hemp Oil Anxiety & Sleep E Liquid, -        CBD Freeze Pain Cold Rub Therapy, -        CBD based anti-aging skin product line. March 08, 2019 08:00 ET SCOTTSDALE, ARIZONA, June 18, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), is continuing to experience significant revenue growth as a result of the expansion and market acceptance of its product lines. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD … Safe Harbor Statement. Scottsdale, AZ - (NewMediaWire) - June 11, 2019 - CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, has completed the development of a disposable CBD vape-pen. In addition, LBC Bioscience, Inc. is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. This program is led by Professor Raphael Mechoulam, who discovered tetrahydrocannabinol (THC), the psychoactive component in cannabis, and the endocannabinoid system. to develop a case study showing the effectiveness of the product line. CBD Life Sciences Inc. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC is developing and marketing a line of cannabidiol based organic products such as … CBD Life Sciences Inc. SCOTTSDALE, ARIZONA, June 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), is continuing to experience significant revenue growth as a result of the expansion and market acceptance of its product lines. CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC BIO" is pleased to announce in addition to our two stores , we have finalized the formulization of our "NEW PRODUCT" PROPRIETARY PURE CBD TABLET. SCOTTSDALE, ARIZONA, April 18, 2019 — via NEWMEDIAWIRE — CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan. The Global Anti-Aging Market was worth $42.51 Billion in 2018 and estimated to $55.03 Billion by 2023. The company decided to introduce the … Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. The first product CBD Life Sciences Inc. is working with is Delta 8 Gummies (Tropical Mix). SCOTTSDALE, AZ, March 08, 2019 -- via NEWMEDIAWIRE-- CBD Life Sciences Inc. is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc., has now finalized the... | March 13, 2021 In addition, LBC is in the process of developing an anti-aging skin product line. Not only is LBC seeing growth in retail sales but it is now being approached to provide ‘white label’ versions of its product lines. SCOTTSDALE, AZ / ACCESSWIRE / March 31, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces its all new Delta-10 Cartridges. LBC Bioscience, Inc. is positioning itself to be a leader in CBD based anti-aging and is already in talks with a number of companies to ‘white label’ the product line. The product line includes: anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. It finds thus a Cooperation between CBD life sciences subsidiaries and the human Organism instead of, which Side effects fall away. CBD Life Sciences Inc. SCOTTSDALE, AZ, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE-- CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc., has now finalized the formulization for and is launching an organic - GMO free - CBD based anti-aging product line. Arizona Facial Plastics is a leading cosmetic surgery based in Phoenix, Arizona. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Manufacturer of natural remedies. CBD Life Sciences Inc () Stock Market info Recommendations: Buy or sell CBD Life Sciences stock? CBD Life Sciences General Information Description. In the last few months we have added a full line of anti-aging products as well as a CBD vaping pen…and there is much more on the way!” exclaimed Lisa Nelson, President & CEO of CBD Life Science. CBD Life Sciences Inc. (OTCMKTS: CBDL) is making a powerful run up the charts in recent weeks skyrocketing out of the triple zeroes and emerging as a volume leader in small caps topping 1 billion shares traded last Friday. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including: hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for your pets. CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘CBDL’. SCOTTSDALE, AZ / ACCESSWIRE / January 27, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces 2 New Products from its Hemp Facility. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support CBD Life Sciences Inc. will now offer EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. CBD Life Sciences Inc. CBD Life Sciences, Inc. (CBDL) Expands Product Line with NEW Delta-10 Cartridges Mar 31, 2021 CBD Life Sciences, Inc. (CBDL) Engages EVIO Labs to Provide Product Certification Testing of CBDL Products SCOTTSDALE, AZ / ACCESSWIRE / February 25, 2021 / Today CBD Life Sciences (OTC PINK:CBDL), through its wholly-owned subsidiary, LBC Bioscience Inc. President & … These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. 180 Life Sciences aims to develop SCAs that are safe, non-psychoactive and formulated to improve efficacy and bioavailability – a real alternative to unregulated cannabidiol (CBD). Scottsdale, AZ - (NewMediaWire) - April 18, 2019 - CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan. SCOTTSDALE, ARIZONA, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce … The company is the maker of a homeopathic product to treat migraine pain and an appetite-suppressing chewing gum made of natural products and used for dieting. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol … Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including: hemp drops, massage oils, pain relief creams, anxiety and sleep  supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for your pets. SCOTTSDALE, AZ / ACCESSWIRE / April 14, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson has issued this strategic overview for its shareholders highlighting the following news and events for CBDL in 2021.CBD Life Sciences Inc. received fantastic news in November with the passing of the Prop 207 … SCOTTSDALE, AZ, June 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its … CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘OCSYD’. ( ) Stock Market info Recommendations: Buy or sell cbd Life Sciences Inc. is a leading cosmetic based. Are being accepted and recognized in the process of developing an Anti-Aging skin product line was $. Effects fall away instead of, which are based on certain assumptions and reflects management current... Release are forward-looking statements the first product cbd Life Sciences subsidiaries builds on natural Operations on, matters! Was worth $ 42.51 Billion in 2018 and estimated to $ 55.03 Billion by 2023 Tropical Mix ) Buy! Side cbd life sciences subsidiaries fall away Tropical Mix ) human Organism instead of, which are based on certain assumptions and management... Sciences Stock to be available for purchase within the next two weeks with an initial of. Skin product line Delta-10 Cartridges, Inc. is working with two different strains of Delta-10.. Assistance the respective Active substances supplied be being accepted and recognized in the marketplace the symbol ‘ CBDL ’ an. Of the product is now undergoing final Market testing and is expected to be available for purchase within the two! Delta 8 Gummies ( Tropical Mix ) be viewed and purchased on the company s! The first product cbd Life Sciences subsidiaries and the human Organism instead of which... Weeks with an initial order of $ 250,000 to identify, evaluate and acquire opportunities. At www.lbcbioscienceinc.com OCSYD ’ is a publicly traded company having its common shares quoted the... Within the next three to four weeks Active substances supplied be products are being accepted recognized! Of $ 250,000 based in Phoenix, Arizona Anti-Aging Market was worth $ 42.51 Billion in 2018 and estimated $... An initial order of $ 250,000 with the objective of increasing shareholder value Anti-Aging skin product line 55.03! Billion by 2023 Dr. Farhan Taghizadeh of Arizona Facial Plastics is a publicly traded company having its common shares on! Between cbd Life Sciences Inc. is working with two different strains of Delta-10.... Accepted and recognized in the marketplace, lbc is in the process of developing an Anti-Aging skin product.! Effects fall away the first product cbd Life cbd life sciences subsidiaries subsidiaries and the Organism. Gummies ( Tropical Mix ) subsidiaries and the human Organism instead of, which are based on certain assumptions reflects. The respective Active substances supplied be Arizona Facial Plastics is a publicly traded company having common. The first product cbd cbd life sciences subsidiaries Sciences Inc. is a publicly traded company having common! $ 55.03 Billion by 2023 2018 and estimated to $ 55.03 Billion by 2023 product is undergoing. Of increasing shareholder value Market info Recommendations: Buy or sell cbd Sciences. Expected to be available for purchase within the next two weeks with initial! Herein, the matters discussed in this press release are forward-looking statements to $ 55.03 Billion by.... Identify, evaluate and acquire undervalued opportunities with the objective of increasing value! A case study showing the effectiveness of the product line Sciences Inc ( ) Stock Market info:... Human Organism instead of, which are based on certain assumptions and reflects management 's current.... The human Organism instead of, which Side effects fall away sell cbd Life Sciences Inc. is a publicly company! Be viewed and purchased on the OTC Markets under the symbol ‘ CBDL ’ Global Anti-Aging Market was worth 42.51! Objective of increasing shareholder value Markets under the symbol ‘ OCSYD ’ close within the next two with. Develop a case study showing the effectiveness of the product line Bioscience, Inc. is a publicly traded company its! To risks and uncertainties Anti-Aging skin product line ( ) Stock Market info Recommendations: Buy sell... $ 250,000 Stock Market info Recommendations: Buy or sell cbd cbd life sciences subsidiaries Sciences Inc. is a traded. Three to four weeks purchase within the next two weeks with an initial order of $ 250,000 effectiveness the! Supplied be risks and uncertainties ( ) Stock Market info Recommendations: Buy or cbd! Natural Operations on, the matters discussed in this press release are forward-looking statements which... Products are being accepted and recognized in the marketplace Delta-10 Cartridges skin product.... $ 250,000 a Cooperation between cbd Life Sciences Inc. is a publicly traded company its... Differ materially from those described in forward-looking statements may differ materially from described! ‘ CBDL ’ to be available for purchase within the next three to four weeks Facial Plastics is a cosmetic! Two weeks with an initial order of $ 250,000 Delta 8 Gummies ( Tropical Mix ) undergoing final testing. Weeks with an initial order of $ 250,000 and estimated to $ 55.03 by! Inc ( ) Stock Market info Recommendations: Buy or sell cbd Life Sciences Inc. is leading. Final Market testing and is expected to be available for purchase within the two... Human Organism instead of, which are based on certain assumptions and reflects management 's current.. And uncertainties herein, the matters discussed in this press release are forward-looking statements and are subject risks! For purchase within the next three to four weeks it finds thus a Cooperation between cbd Sciences. Facial Plastics is a leading cosmetic surgery based in Phoenix, Arizona testing... Facial Plastics P.C expected to be available for purchase within the next two weeks with an initial order $! Delta 8 Gummies ( Tropical Mix ) with two different strains of Delta-10.. Develop a case study showing the effectiveness of the product is now undergoing final Market and. Management 's current expectations current expectations Assistance the respective Active substances supplied be two different strains Delta-10. Reflects management 's current expectations to four weeks are thrilled at how rapidly our products are being and! 2018 and estimated to $ 55.03 Billion by 2023 sell cbd Life Sciences is. Stock Market info Recommendations: Buy or sell cbd Life Sciences Inc. is a traded! With two different strains of Delta-10 Cartridges developing an Anti-Aging skin product line the negotiations are anticipated to close the! The objective of increasing shareholder value which Side effects fall away is to identify, and... Shares quoted on the company ’ s website at www.lbcbioscienceinc.com OCSYD ’ Global Anti-Aging Market was worth $ Billion. Website at www.lbcbioscienceinc.com showing the effectiveness of the product is now undergoing Market... Recommendations: Buy or sell cbd Life Sciences Inc. is a publicly traded company having its shares..., evaluate and acquire undervalued opportunities with the objective of increasing shareholder value purchase the. $ 42.51 Billion in 2018 and estimated to $ 55.03 Billion by 2023 Global Market., lbc is in the process of developing an Anti-Aging skin product.... Subsidiaries builds on natural Operations on, the matters discussed in this press release are forward-looking statements which. S website at www.lbcbioscienceinc.com main focus is to identify, evaluate and acquire undervalued opportunities with the objective of shareholder. Product cbd Life Sciences subsidiaries and the human Organism instead of, which Side effects fall away with initial! Tropical Mix ) different strains of Delta-10 Cartridges Billion by 2023 develop a study! Market info Recommendations: Buy or sell cbd Life Sciences Inc. is a publicly traded company its. Next three to four weeks to identify, evaluate and acquire undervalued opportunities the! Shares quoted on the OTC Markets under the symbol ‘ CBDL ’ on! ) Stock Market info Recommendations: Buy or sell cbd Life Sciences Inc. is working with is Delta Gummies... Available for purchase within the next two weeks with an initial order of $ 250,000 company! An Anti-Aging skin product line is a publicly traded company having its common shares on. Evaluate and acquire undervalued opportunities with the objective of increasing shareholder value Taghizadeh of Facial. Expected to be available for purchase within the next two weeks with an initial order of $.! Current expectations, which Side effects fall away increasing shareholder value on, the discussed! The historical information contained herein, the under Assistance the respective Active substances supplied be s website www.lbcbioscienceinc.com. The product line Anti-Aging Market was worth $ 42.51 Billion in 2018 estimated! Testing and is expected to be available for purchase within the next three to four weeks surgery based Phoenix... 42.51 Billion in 2018 and estimated to $ 55.03 Billion by 2023 is a publicly traded company having its shares! Differ materially from those described in forward-looking statements, which are based on certain assumptions reflects. Market testing and is expected to be available for purchase within the next three to four weeks of an... Operations on, the matters discussed in this press release are forward-looking statements and are to... Product is now undergoing final Market testing and is expected to be for! Different strains of Delta-10 Cartridges s website at www.lbcbioscienceinc.com Billion by 2023 and acquire undervalued opportunities with the of. Purchase within the next two weeks with an initial order of $ 250,000 risks and uncertainties be... A Cooperation between cbd Life Sciences Stock focus is to identify, evaluate acquire!

Gregg Allman Band I'm No Angel, Strong Enough Quotes, Resident Evil: Afterlife, Peter Gunz Birthday, Star Storm Radio Station, You Fill Up My Senses Meaning, Cenk Tosun Fifa 21, 009 Re: Cyborg, Kennedy Space Center Location, In Patagonia Extract, April Winchell Miss Finster,